JP Morgan maintains Aveanna Healthcare at Neutral
JP Morgan maintained its Neutral rating on Aveanna Healthcare and raised its price target to $15.00 from $8.00, per Benzinga.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
JP Morgan maintained its Neutral rating on Aveanna Healthcare and raised its price target to $15.00 from $8.00, per Benzinga.